Developing a new intravaginal ring to prevent pregnancy and STIs
Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology
['FUNDING_OTHER'] · POPULATION COUNCIL · NIH-10914837
This study is testing a new, easy-to-use ring that women can wear for a month to help prevent both unwanted pregnancies and sexually transmitted infections, including HIV, making it a great option for those looking for complete protection without hormones.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | POPULATION COUNCIL (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10914837 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a non-hormonal intravaginal ring that can be used for 30 days to prevent both unintended pregnancies and sexually transmitted infections, including HIV. The ring contains active ingredients that work together to provide contraceptive and anti-infection benefits. The research involves formulating and manufacturing the ring, ensuring it meets safety and effectiveness standards, and conducting user preference studies to refine its design. By addressing both pregnancy and STI prevention, this project aims to meet the needs of women who prefer comprehensive protection.
Who could benefit from this research
Good fit: Ideal candidates for this research are women of reproductive age who are seeking effective contraception and protection against STIs.
Not a fit: Patients who are not sexually active or those who are not concerned about pregnancy or STIs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide women with a convenient and effective method to prevent both unintended pregnancies and sexually transmitted infections.
How similar studies have performed: Previous research has shown promise in developing multipurpose prevention technologies, indicating potential for success in this innovative approach.
Where this research is happening
NEW YORK, UNITED STATES
- POPULATION COUNCIL — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HADDAD, LISA BLAKE — POPULATION COUNCIL
- Study coordinator: HADDAD, LISA BLAKE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus